• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Highlights of India’s first Biotech startup Expo
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid
  • Moderna and Pfizer: Lawsuits and Charitable Giving
  • European Commission Approves Two GM Crops for Food and Feed
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

    January 24, 2022

    Interview: Prof Kailash Chander Bansal, Secretary, National Academy of Agricultural Sciences (NAAS), India

    January 23, 2022

    Interview – Dr Heera Lal: How an IAS officer using Biotech approaches to transform Indian villages into “Organic Villages”

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»Articles»No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible?

No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible?

0
By Biotech Express on May 19, 2022 Articles, Articles- Editorials, SARS- CoV2 & COVID-19 Updates

An Aurangabad resident has approached Bombay High Court seeking compensation of Rs 1000 crore from the Maharashtra government, Centre and Serum Institute of India claiming his daughter, a medical student, died due to side effects of the Covishield vaccine that she was administered in January 2021.

Since the covid vaccination started many individuals are complaining about serious vaccine side effects, most of them reported in Covishield and include blood clotting events in various parts of body. These adverse events are creating many unexpected outcomes in patients like blindness, heart attacks and many more as reported in article appeared in Biotech Express in April 2022 issue.( http://www.biotechexpressmag.com/editorial-what-serious-side-effects-reported-after-inoculation-of-indian-covid-19-vaccines-survey-of-aefi-reports/)

Experts from the field expect that these adverse events are much more than reported in AEFI as the reporting system is not strong enough like developed countries and thus many adverse events go unnoticed. The presence of adverse events in AEFI show us that indeed COVID vaccines have side effects but what will be the compensation for these adverse events either from vaccine makers or government is not clear yet.

Though the government has always said that vaccine is not mandatory but limiting living resources like food, transportation etc. to unvaccinated individuals has forced people to take some action and toward this many NGOs and experts have come forward. Due to their consistent efforts a recent order from supreme court allowed people to choose whether to vaccinate or not and no restrictions on unvaccinated.

That is OK, but what will be the compensation for vaccine injuries is still a matter of concern as many people have lost their lives due to vaccine side effects and many of them have become ill for lifetime.

These covid vaccines were approved in emergency mode but was forced to take in non emergent situation like Petitioner Dilip Lunawat, who filed the plea before the principal bench of HC Bombay, claimed about his daughter Snehal, a medical student in Nashik, who was administered both doses of the vaccine as part of the state government’s initiative to vaccinate all health care workers. The plea said Snehal was assured the COVID vaccine was completely safe, and posed no risk or threat to the body, and was, therefore, compelled to take vaccine at the college since she was a health worker. He said his daughter took the vaccine on January 28, 2021 and died a few weeks later on March 1 due to the side effects of those vaccines. He is seeking compensation of Rs 1000 crore from the Maharashtra government, Centre and Serum Institute of India. (https://www.india.com/maharashtra/maharashtra-man-claims-daughter-died-of-covid-vaccine-side-effects-seeks-rs-1000-core-compensation-5218452/)

The government of India has stated in Parliament that there is no provision of compensation for any side-effects or medical complications (adverse events) due to inoculation under emergency-use but an individual can still take legal recourse to get compensated. Specifically, if, there are adverse side-effects from a vaccination manufactured or administered by any agency, resulting in loss or injury to the vaccinated, including permanent-disablement or death then a legal-action can be brought by the injured-party or his or her representative in a Court of Law under Fatal Accidents Act of 1855.

Similar case of vaccine death in India due to covishield was filed in the Kerala High Court by the parents of a 19-year-old girl, who died allegedly due to a rare-immunogenic response to the Covishield vaccine seeking compensation of Rs 10 crore. The 19-year-old postgraduate student began feeling unwell a day after getting the Covishield vaccine, as per the petition. A week later, the girl was taken to the hospital where she was given symptomatic treatment and discharged the same day. The girl passed away on 12 August, 2021 exactly two weeks after she was administered the vaccine with the official post-mortem report stating that the cause of death was inter-cranial bleeding. Further, it found that the girl might have suffered from thrombocytopenia, thrombosis syndrome, which is supposed to be a rare immunogenic response to the COVID-19 vaccines. (https://www.firstpost.com/india/couple-moves-kerala-high-court-seeking-rs-10-crore-compensation-alleging-daughters-death-due-to-covishield-vaccine-10563821.html)

Compensation suit are not only restricted to India, in Taiwan, a panel of experts appointed by the Ministry of Health and Welfare agreed that the government should pay NT$6 million (US$209,025) in the case of a woman, whose death is the first to be classified as directly related to receiving a COVID-19 vaccine shot in Taiwan. Because the woman did not have any chronic ailments, nor other conditions that could explain a very rare blood-clotting disorder called “thrombosis with thrombocytopenia syndrome,” a known side effect of the AstraZeneca vaccine she received, the panel determined that her death was linked to the vaccine, Chuang said. The woman was a Taipei resident in her 50s, who was identified only by her surname Yu. She died of a brain hemorrhage, a complication caused by the syndrome, according to the panel’s findings. (https://focustaiwan.tw/society/202203290026)
As per data with Australian government, 37.8 million vaccine doses had been administered till November 7, 2021 and 78,880 adverse events linked to vaccination were recorded. A portal was being made to enable people to claim damages. At least 10,000 people have registered interest to make a claim, till the report came on news portal. (https://www.wionews.com/world/thousands-of-australians-want-compensation-for-covid-vaccine-side-effects-report-429883).

In UK, Up to 920 compensation applications have been filed by people who were left seriously injured after getting the Covid-19 vaccine as claims could hit £110million. Vikki Spit, from Alston, Cumbria, hopes to qualify for financial support after her fiancé Zion, 48, died of a brain haemorrhage two weeks after getting the AstraZeneca vaccine in May 2021. She claimed his death certificate named the AstraZeneca vaccine but said she has been left in ‘limbo’ after applying for the scheme in June. (https://www.dailymail.co.uk/news/article-10556213/Covid-vaccine-claims-hit-110m-920-compensation-applications-filed.html)

So, the compensation mechanism exist in most developed countries and many of the vaccine adverse events injuries have been compensated appropriately but will it happen in India is still an important question. In case, the kin of injured people can go to courts as per the directions from the government for which they need proofs but will they be able to provide proof is still another question as AEFI has not registered all the adverse events. Recently, after thorough studies and suggestions from the experts, Supreme court of India has removed any kind of COVID vaccine mandate.

by Kamal Pratap Singh

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Researchers who jumped into the field from distant disciplines published lower impact work, study finds

Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid

Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha

Leave A Reply Cancel Reply

Current Issue – May 2022

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Highlights of India’s first Biotech startup Expo June 13, 2022
  • NTU Singapore scientists develop a ‘fabric’ that turns body movement into electricity June 6, 2022
  • Researchers who jumped into the field from distant disciplines published lower impact work, study finds May 30, 2022
  • Amrita Vishwa Vidyapeetham gets CDSCO nod for clinical trials of first-of-its-kind synthetic jaw-bone graft May 26, 2022
  • AstraZeneca Covid-19 vaccines which uses a chimpanzee adenovirus inked to monkeypox outbreak May 25, 2022
  • Concerns Mount Over COVID-19 ‘Rebounds’ After Treatment With Pfizer’s Paxlovid May 25, 2022
  • Moderna and Pfizer: Lawsuits and Charitable Giving May 25, 2022
  • European Commission Approves Two GM Crops for Food and Feed May 25, 2022
  • Ayush Ministry, DBT sign MoU for cooperation on evidence-based biotech interventions in Ayush sector May 24, 2022
  • CCI, India merger approved absorption of Covidshield Technologies into Biocon Biologics May 20, 2022
  • No Vaccine Mandates after supreme court order, next compensation to AEFI survivors from COVID Vaccine makers possible? May 19, 2022
  • Industry lobbying on WHO overshadowing public health policy, researchers suggest May 18, 2022
  • Letter: Public Health Bill to be presented in the Monsoon session 2022 is Illegal, Unconstitutional and Arbitrary: Dr Maya Valecha May 15, 2022
  • Paid publishing in science has killed peer review system, says CSIR’s ex-chief Shekhar Mande May 15, 2022
  • Bill Gates tests positive for COVID-19 even after many booster doses, mocked on twitter May 10, 2022
  • Another Ivermectin COVID-19 paper retracted May 8, 2022
  • COVID-19 spike protein paper retracted May 7, 2022
  • Killer Music? Can sound make a clot in a boy who died while dancing or it is related to COVID vaccination May 7, 2022
  • Clotting Risks Cause FDA to Restrict Use of J&J COVID Vaccine May 6, 2022
  • Department of Pharmaceuticals releases “Common Guidelines on Pharmaceutical Innovation and Entrepreneurship” for academic institutions May 6, 2022
  • No medical care for 45% of recorded deaths in 2020, highest ever in India: New data May 6, 2022
  • Indian opposition seeks higher compensation for COVID deaths after damning WHO report May 6, 2022
  • Redcliffe Lifetech raises $61 million in Series B funding May 6, 2022
  • Engineers Create an Enzyme That Breaks Down Plastic Waste in Hours, Not Decades May 5, 2022
  • Eris Lifesciences acquires 100% stake in Oaknet Healthcare for Rs 650 cr May 5, 2022
  • The Union Government has Lied to the Supreme Court in COVID Vaccines Case? May 5, 2022
  • COVID-19- vitamin D paper from India retracted by Springer Nature journal May 4, 2022
  • IISc develops 3D printed gloves for rehabilitating stroke patients May 4, 2022
  • A new wearable technology — for plants May 4, 2022
  • Sanofi India names Rodolfo Hrosz managing director effective June 1 May 4, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.